MedTrace Logo

Performance of Two Silicone Hydrogel Toric Contact Lenses

NCT00638846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2015-05-21

Study results available
· View outcomes & findings →

Summary

Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.

Conditions

  • Vision Correction

Interventions

DEVICE

senofilcon A toric

silicone hydrogel toric lens, worn daily for 2 wks (2wks replacement)

DEVICE

balafilcon A toric

silicone hydrogel toric lens, worn daily for 2 wks (2wks replacement)

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Graeme YOung, MPhil PhD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00638846 on ClinicalTrials.gov